KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 20 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,215,000 | -3.4% | 8,000,000 | 0.0% | 9.09% | +14.7% |
| Q2 2023 | $5,400,000 | -30.9% | 8,000,000 | -20.0% | 7.93% | +11.9% |
| Q1 2023 | $7,819,180 | +0.9% | 10,000,000 | 0.0% | 7.08% | +84.4% |
| Q4 2022 | $7,750,000 | -4.8% | 10,000,000 | 0.0% | 3.84% | +20.8% |
| Q3 2022 | $8,145,000 | +24.1% | 10,000,000 | +11.1% | 3.18% | +22.0% |
| Q2 2022 | $6,561,000 | -12.9% | 9,000,000 | 0.0% | 2.60% | -15.3% |
| Q1 2022 | $7,529,000 | +84.2% | 9,000,000 | +80.0% | 3.08% | +66.2% |
| Q4 2021 | $4,088,000 | – | 5,000,000 | – | 1.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 9,000,000 | $6,561,000 | 2.60% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,050,000 | $22,600,000 | 0.52% |
| Context Capital Management, LLC | 7,000 | $5,079,000 | 0.36% |
| DeepCurrents Investment Group LLC | 11,890,000 | $8,569,000 | 0.34% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $18,139,000 | 0.31% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,500,000 | $4,046,000 | 0.02% |
| LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $12,872,000 | 0.02% |
| BLB&B Advisors, LLC | 100,000 | $73,000 | 0.01% |
| MACKAY SHIELDS LLC | 221,000 | $163,000 | 0.00% |
| JPMORGAN CHASE & CO | 900,000 | $655,000 | 0.00% |